These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 19628781)

  • 1. Immune depletion with cellular mobilization imparts immunoregulation and reverses autoimmune diabetes in nonobese diabetic mice.
    Parker MJ; Xue S; Alexander JJ; Wasserfall CH; Campbell-Thompson ML; Battaglia M; Gregori S; Mathews CE; Song S; Troutt M; Eisenbeis S; Williams J; Schatz DA; Haller MJ; Atkinson MA
    Diabetes; 2009 Oct; 58(10):2277-84. PubMed ID: 19628781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy.
    Tian B; Hao J; Zhang Y; Tian L; Yi H; O'Brien TD; Sutherland DE; Hering BJ; Guo Z
    Transplantation; 2009 Jan; 87(2):198-206. PubMed ID: 19155973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination Therapy Reverses Hyperglycemia in NOD Mice With Established Type 1 Diabetes.
    Xue S; Posgai A; Wasserfall C; Myhr C; Campbell-Thompson M; Mathews CE; Brusko T; Rabinovitch A; Savinov A; Battaglia M; Schatz D; Haller M; Atkinson MA
    Diabetes; 2015 Nov; 64(11):3873-84. PubMed ID: 26185279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of new-onset diabetes through modulating inflammation and stimulating beta-cell replication in nonobese diabetic mice by a dipeptidyl peptidase IV inhibitor.
    Tian L; Gao J; Hao J; Zhang Y; Yi H; O'Brien TD; Sorenson R; Luo J; Guo Z
    Endocrinology; 2010 Jul; 151(7):3049-60. PubMed ID: 20444936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Murine antithymocyte globulin therapy alters disease progression in NOD mice by a time-dependent induction of immunoregulation.
    Simon G; Parker M; Ramiya V; Wasserfall C; Huang Y; Bresson D; Schwartz RF; Campbell-Thompson M; Tenace L; Brusko T; Xue S; Scaria A; Lukason M; Eisenbeis S; Williams J; Clare-Salzler M; Schatz D; Kaplan B; Von Herrath M; Womer K; Atkinson MA
    Diabetes; 2008 Feb; 57(2):405-14. PubMed ID: 18039815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-thymoglobulin (ATG) treatment does not reverse type 1 diabetes in the acute virally induced rat insulin promoter-lymphocytic choriomeningitis virus (RIP-LCMV) model.
    Bresson D; von Herrath MG
    Clin Exp Immunol; 2011 Mar; 163(3):375-80. PubMed ID: 21235534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of double negative T cells and anti-thymocyte serum reverses type 1 diabetes in NOD mice.
    Liu T; Cong M; Sun G; Wang P; Tian Y; Shi W; Li X; You H; Zhang D
    J Transl Med; 2016 Feb; 14():57. PubMed ID: 26911290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoregulatory effect of anti-thymocyte globulin monotherapy on peripheral lymphoid tissues of non-obese diabetic mice.
    Vargova L; Zacharovova K; Dovolilova E; Vojtova L; Saudek F
    Transplant Proc; 2011 Nov; 43(9):3277-80. PubMed ID: 22099776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Granulocyte-macrophage colony-stimulating factor prevents diabetes development in NOD mice by inducing tolerogenic dendritic cells that sustain the suppressive function of CD4+CD25+ regulatory T cells.
    Gaudreau S; Guindi C; Ménard M; Besin G; Dupuis G; Amrani A
    J Immunol; 2007 Sep; 179(6):3638-47. PubMed ID: 17785799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-Dose Anti-Thymocyte Globulin Preserves C-Peptide, Reduces HbA
    Haller MJ; Long SA; Blanchfield JL; Schatz DA; Skyler JS; Krischer JP; Bundy BN; Geyer SM; Warnock MV; Miller JL; Atkinson MA; Becker DJ; Baidal DA; DiMeglio LA; Gitelman SE; Goland R; Gottlieb PA; Herold KC; Marks JB; Moran A; Rodriguez H; Russell WE; Wilson DM; Greenbaum CJ;
    Diabetes; 2019 Jun; 68(6):1267-1276. PubMed ID: 30967424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dendritic cell-expanded, islet-specific CD4+ CD25+ CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice.
    Tarbell KV; Petit L; Zuo X; Toy P; Luo X; Mqadmi A; Yang H; Suthanthiran M; Mojsov S; Steinman RM
    J Exp Med; 2007 Jan; 204(1):191-201. PubMed ID: 17210729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antithymocyte Globulin Plus G-CSF Combination Therapy Leads to Sustained Immunomodulatory and Metabolic Effects in a Subset of Responders With Established Type 1 Diabetes.
    Haller MJ; Gitelman SE; Gottlieb PA; Michels AW; Perry DJ; Schultz AR; Hulme MA; Shuster JJ; Zou B; Wasserfall CH; Posgai AL; Mathews CE; Brusko TM; Atkinson MA; Schatz DA
    Diabetes; 2016 Dec; 65(12):3765-3775. PubMed ID: 27669730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesenchymal stem cells protect NOD mice from diabetes by inducing regulatory T cells.
    Madec AM; Mallone R; Afonso G; Abou Mrad E; Mesnier A; Eljaafari A; Thivolet C
    Diabetologia; 2009 Jul; 52(7):1391-9. PubMed ID: 19421731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homotaurine Treatment Enhances CD4
    Tian J; Dang H; O'Laco KA; Song M; Tiu BC; Gilles S; Zakarian C; Kaufman DL
    Immunohorizons; 2019 Oct; 3(10):498-510. PubMed ID: 31636084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of combination therapy with dipeptidyl peptidase-IV and histone deacetylase inhibitors in the non-obese diabetic mouse model of type 1 diabetes.
    Cabrera SM; Colvin SC; Tersey SA; Maier B; Nadler JL; Mirmira RG
    Clin Exp Immunol; 2013 Jun; 172(3):375-82. PubMed ID: 23600825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-10 gene transfer into insulin-producing β cells protects against diabetes in non-obese diabetic mice.
    Xu A; Zhu W; Li T; Li X; Cheng J; Li C; Yi P; Liu L
    Mol Med Rep; 2015 Sep; 12(3):3881-3889. PubMed ID: 25998958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Both CD4+ and CD8+ T-cells in syngeneic islet grafts in NOD mice produce interferon-gamma during beta-cell destruction.
    Suarez-Pinzon W; Rajotte RV; Mosmann TR; Rabinovitch A
    Diabetes; 1996 Oct; 45(10):1350-7. PubMed ID: 8826970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mobilization without immune depletion fails to restore immunological tolerance or preserve beta cell function in recent onset type 1 diabetes.
    Haller MJ; Atkinson MA; Wasserfall CH; Brusko TM; Mathews CE; Hulme M; Cintron M; Shuster J; McGrail K; Posgai A; Schatz D
    Clin Exp Immunol; 2016 Mar; 183(3):350-7. PubMed ID: 26462724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perturbed homeostasis of peripheral T cells elicits decreased susceptibility to anti-CD3-induced apoptosis in prediabetic nonobese diabetic mice.
    Yang W; Hussain S; Mi QS; Santamaria P; Delovitch TL
    J Immunol; 2004 Oct; 173(7):4407-16. PubMed ID: 15383571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The type and frequency of immunoregulatory CD4+ T-cells govern the efficacy of antigen-specific immunotherapy in nonobese diabetic mice.
    Pop SM; Wong CP; He Q; Wang Y; Wallet MA; Goudy KS; Tisch R
    Diabetes; 2007 May; 56(5):1395-402. PubMed ID: 17317763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.